Moreover, chemotherapeutic mixture consisting of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)-resistant DLBCL cells expressed markedly higher levels of YWHAZ than CHOP-sensitive cells 49. Here, DDIT3 is linked to diffuse large B-cell lymphoma.